{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:09:33Z","timestamp":1783566573633,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81570156, No.81570425, N0. 81770126"],"award-info":[{"award-number":["No.81570156, No.81570425, N0. 81770126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["N0. 81700156"],"award-info":[{"award-number":["N0. 81700156"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12015-020-10054-1","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T18:02:58Z","timestamp":1603130578000},"page":"616-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-3366","authenticated-orcid":false,"given":"Pengcheng","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3995-0340","authenticated-orcid":false,"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-6657","authenticated-orcid":false,"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3956-3372","authenticated-orcid":false,"given":"Haijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-6685","authenticated-orcid":false,"given":"Manman","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-5020","authenticated-orcid":false,"given":"Naying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9746-3914","authenticated-orcid":false,"given":"Yirong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4438","authenticated-orcid":false,"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"10054_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky, I., & Abdul-Hay, M. (2016). Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer Journal, 6, e441.","journal-title":"Blood Cancer Journal"},{"issue":"12","key":"10054_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"T Daniel","year":"2017","unstructured":"Daniel, T., & Ravindra, M. (2017). Biology and relevance of human acute myeloid leukemia stem cells. Blood, 129(12), 1577\u20131585.","journal-title":"Blood"},{"key":"10054_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.hemonc.2017.05.021","volume":"10","author":"AA Kassim","year":"2017","unstructured":"Kassim, A. A., & Savani, B. N. (2017). Hematopoietic stem cell transplantation for acute myeloid leukemia: A review. Hematology\/Oncology and Stem Cell Therapy, 10, 245\u2013251.","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"issue":"5","key":"10054_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/em.22087","volume":"58","author":"N Chatterjee","year":"2017","unstructured":"Chatterjee, N., & Walker, G. C. (2017). Mechanisms of DNA damage, repair, and mutagenesis. Environmental and Molecular Mutagenesis, 58(5), 235\u2013263.","journal-title":"Environmental and Molecular Mutagenesis"},{"issue":"5","key":"10054_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4161\/cbt.23761","volume":"14","author":"D Woods","year":"2013","unstructured":"Woods, D., & Turchi, J. J. (2013). Chemotherapy induced DNA damage response. Cancer Biology & Therapy, 14(5), 379\u2013389.","journal-title":"Cancer Biology & Therapy"},{"key":"10054_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.12.038","volume":"358","author":"H Tian","year":"2015","unstructured":"Tian, H., Gao, Z., Li, H. Z., Zhang, B. F., Wang, G., Zhang, Q., et al. (2015). DNA damage response \u2013 A double-edged sword in cancer prevention and cancer therapy. Cancer Letters, 358, 8\u201316.","journal-title":"Cancer Letters"},{"issue":"4","key":"10054_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molcel.2019.05.036","volume":"75","author":"C Colomer","year":"2019","unstructured":"Colomer, C., Margalef, P., Villanueva, A., Vert, A., Pecharroman, I., Sol\u00e9, L., et al. (2019). IKK\u03b1 kinase regulates the DNA damage response and drives chemo-resistance in cancer. Molecular Cell, 75(4), 669\u2013682.e5.","journal-title":"Molecular Cell"},{"issue":"4","key":"10054_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/carcin\/bgx002","volume":"38","author":"S Biechonski","year":"2017","unstructured":"Biechonski, S., Yassin, M., & Milyavsky, M. (2017). DNA-damage response in hematopoietic stem cells: An evolutionary trade-off between blood regeneration and leukemia suppression. Carcinogenesis, 38(4), 367\u2013377.","journal-title":"Carcinogenesis"},{"issue":"3","key":"10054_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12185-017-2300-7","volume":"106","author":"D Delia","year":"2007","unstructured":"Delia, D., & Mizutani, S. (2007). The DNA damage response pathway in normal hematopoiesis and malignancies. International Journal of Hematology, 106(3), 328\u2013334.","journal-title":"International Journal of Hematology"},{"key":"10054_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.dnarep.2007.05.007","volume":"6","author":"DC Dartsch","year":"2007","unstructured":"Dartsch, D. C., & Gieseler, F. (2007). Repair of idarubicin-induced DNA damage: A cause of resistance? DNA Repair, 6, 1618\u20131628.","journal-title":"DNA Repair"},{"issue":"2","key":"10054_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/15384047.2019.1679555","volume":"21","author":"H Li","year":"2020","unstructured":"Li, H., Li, L., Mei, H., Pan, G., Wang, X., Huang, X., Wang, T., Jiang, Z., Zhang, L., & Sun, L. (2020). Antitumor properties of triptolide: Phenotype regulation of macrophage differentiation. Cancer Biology & Therapy, 21(2), 178\u2013188.","journal-title":"Cancer Biology & Therapy"},{"issue":"5","key":"10054_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"P Noel","year":"2019","unstructured":"Noel, P., Von Hoff, D. D., Saluja, A. K., Velagapudi, M., Borazanci, E., & Han, H. (2019). Triptolide and its derivatives as cancer therapies. Trends in Pharmacological Sciences, 40(5), 327\u2013341.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"51","key":"10054_CR13","doi-asserted-by":"publisher","first-page":"85515","DOI":"10.18632\/oncotarget.13454","volume":"7","author":"H Zhao","year":"2016","unstructured":"Zhao, H., Shi, P., Deng, M., Jiang, Z., Li, Y., Kannappan, V., et al. (2016). Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption. Oncotarget, 7(51), 85515\u201385528.","journal-title":"Oncotarget"},{"issue":"13","key":"10054_CR14","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.7150\/jca.30669","volume":"10","author":"G Huang","year":"2019","unstructured":"Huang, G., Hu, H., Zhang, Y., Zhu, Y., Liu, J., Tan, B., et al. (2019). Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT. Journal of Cancer, 10(13), 3012\u20133020.","journal-title":"Journal of Cancer"},{"issue":"11","key":"10054_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2217\/pgs.13.122","volume":"14","author":"F Chen","year":"2013","unstructured":"Chen, F., Liu, Y., Wang, S., Guo, X., Shi, P., Wang, W., et al. (2013). Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1\u03b1 and Nrf2. Pharmacogenomics, 14(11), 1305\u20131317.","journal-title":"Pharmacogenomics"},{"key":"10054_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2019.07.003","volume":"461","author":"Q Yang","year":"2019","unstructured":"Yang, Q., Chen, K., Zhang, L., Feng, L., Fu, G., Jiang, S., Bi, S., Lin, C., Zhou, Y., Zhao, H., Chen, X. L., Fu, G., & Xu, B. (2019). Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway. Cancer Letters, 461, 31\u201343.","journal-title":"Cancer Letters"},{"key":"10054_CR17","doi-asserted-by":"publisher","first-page":"e948","DOI":"10.1038\/cddis.2013.467","volume":"4","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Chen, F., Wang, S., Guo, X., Shi, P., Wang, W., et al. (2013). Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors. Cell Death & Disease, 4, e948.","journal-title":"Cell Death & Disease"},{"issue":"12","key":"10054_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1182\/blood-2016-10-696039","volume":"129","author":"DA Pollyea","year":"2017","unstructured":"Pollyea, D. A., & Jordan, C. T. (2017). Therapeutic targeting of acute myeloid leukemia stem cells. Blood, 129(12), 1627\u20131635.","journal-title":"Blood"},{"issue":"10","key":"10054_CR19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/17460441.2017.1356818","volume":"12","author":"\u00d8 Bruserud","year":"2017","unstructured":"Bruserud, \u00d8., Aaseb\u00f8, E., Hernandez-Valladares, M., Tsykunova, G., & Reikvam, H. (2017). Therapeutic targeting of leukemic stem cells in acute myeloid leukemia \u2013 The biological background for possible strategies. Expert Opinion on Drug Discovery, 12(10), 1053\u20131065.","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10054_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I., Mitchell, A., Heisler, L., Abelson, S., Ng, S. W. K., Trotman-Grant, A., et al. (2017). Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature, 547, 104\u2013108.","journal-title":"Nature"},{"key":"10054_CR21","doi-asserted-by":"publisher","first-page":"8323592","DOI":"10.1155\/2019\/8323592","volume":"2019","author":"P Bernasconi","year":"2019","unstructured":"Bernasconi, P., & Borsani, O. (2019). Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment. Journal of Oncology, 2019, 8323592.","journal-title":"Journal of Oncology"},{"issue":"1","key":"10054_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbrc.2018.12.115","volume":"509","author":"M Hosokawa","year":"2019","unstructured":"Hosokawa, M., Tanaka, S., Ueda, K., Iwakawa, S., & Ogawara, K. I. (2019). Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine. Biochemical and Biophysical Research Communications, 509(1), 249\u2013254.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10054_CR23","doi-asserted-by":"publisher","first-page":"144195","DOI":"10.1016\/j.gene.2019.144195","volume":"726","author":"M Lyu","year":"2020","unstructured":"Lyu, M., Liao, H., Shuai, X., Jin, Y., Su, J., & Zheng, Q. (2020). The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan. Gene, 726, 144195. https:\/\/doi.org\/10.1016\/j.gene.2019.144195.","journal-title":"Gene"},{"key":"10054_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbmt.2019.09.023","volume":"26","author":"K Pratz","year":"2019","unstructured":"Pratz, K., Rudek, M., Smith, B., Karp, J., Gojo, I., Dezern, A., Jones, R., Greer, J., Gocke, C., Baer, M., Duong, V., Rosner, G., Zahurak, M., Wright, J., Emadi, A., & Levis, M. (2019). A prospective study of peri-transplant sorafenib for FLT3-ITD AML patients undergoing allogeneic transplantation. Biology of Blood and Marrow Transplantation, 26, 300\u2013306. https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.023.","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10054_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/cncr.32534","volume":"126","author":"C Zhang","year":"2019","unstructured":"Zhang, C., Lam, S., Leung, G., Tsui, S.-P., Yang, N., Ng, N., et al. (2019). Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. Cancer., 126, 344\u2013353. https:\/\/doi.org\/10.1002\/cncr.32534.","journal-title":"Cancer."},{"issue":"22","key":"10054_CR26","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1182\/bloodadvances.2019001068","volume":"3","author":"N Beeharry","year":"2019","unstructured":"Beeharry, N., Landrette, S., Gayle, S., Hernandez, M., Grotzke, J. E., Young, P. R., et al. (2019). LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML. Blood Advances, 3(22), 3661\u20133673.","journal-title":"Blood Advances"},{"key":"10054_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney, J. N., & Cotter, T. G. (2018). ROS signalling in the biology of cancer. Seminars in Cell & Developmental Biology, 80, 50\u201364.","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"11","key":"10054_CR28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/cells8111466","volume":"8","author":"M Hong","year":"2019","unstructured":"Hong, M., Li, J., Li, S., & Almutairi, M. M. (2019). Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation. Cells, 8(11), 1466.","journal-title":"Cells"},{"key":"10054_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cas.12366","volume":"105","author":"N Hosoya","year":"2014","unstructured":"Hosoya, N., & Miyagawa, K. (2014). Targeting DNA damage response in cancer therapy. Cancer Science, 105, 370\u2013388.","journal-title":"Cancer Science"},{"key":"10054_CR30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3389\/fonc.2019.01136","volume":"9","author":"S Das","year":"2019","unstructured":"Das, S., Camphausen, K., & Shankavaram, U. (2019). Pan-cancer analysis of potential synthetic lethal drug targets specific to alterations in DNA damage response. Frontiers in Oncology, 9, 1136.","journal-title":"Frontiers in Oncology"},{"key":"10054_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00294-019-01039-w","volume":"66","author":"M Ma","year":"2019","unstructured":"Ma, M., Rodriguez, A., & Sugimoto, K. (2019). Activation of ATR-related protein kinase upon DNA damage recognition. Current Genetics, 66, 327\u2013333.","journal-title":"Current Genetics"},{"issue":"6","key":"10054_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/em.21944","volume":"56","author":"K Rothkamm","year":"2015","unstructured":"Rothkamm, K., Barnard, S., Moquet, J., Ellender, M., Rana, Z., & Burdak-Rothkamm, S. (2015). DNA damage foci: Meaning and significance. Environmental and Molecular Mutagenesis, 56(6), 491\u2013504.","journal-title":"Environmental and Molecular Mutagenesis"},{"issue":"5","key":"10054_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ijc.28226","volume":"134","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., & Hunter, T. (2014). Roles of Chk1 in cell biology and cancer therapy. International Journal of Cancer, 134(5), 1013\u20131023.","journal-title":"International Journal of Cancer"},{"key":"10054_CR34","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1159\/000495899","volume":"51","author":"Q Luo","year":"2018","unstructured":"Luo, Q., Guo, H., Kuang, P., Cui, H., Deng, H., Liu, H., Lu, Y., Wei, Q., Chen, L., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018). Sodium fluoride arrests renal G2\/M phase cell-cycle progression by activating ATM-Chk2-P53\/Cdc25C signaling pathway in mice. Cellular Physiology and Biochemistry, 51, 2421\u20132433. https:\/\/doi.org\/10.1159\/000495899.","journal-title":"Cellular Physiology and Biochemistry"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-020-10054-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:34:05Z","timestamp":1634625245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-020-10054-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10054"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-10054-1","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"5 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was carried out in accordance with the Declaration of Helsinki, and approved by the Ethics Review Board of Nanfang Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Bone marrow aspirates of AML patients and peripheral blood of healthy donors were obtained with the informed consent for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}